Hyperhomocysteinemia and occlusive vascular disease: An emergent role for fibroblast growth factor 2

Circulation Research

Volumn 102, Issue 8, 2008, Pages 869-870

  Medina, Miguel Ángel ^a,b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

DNA methylation; Endothelial cell; FGF2; G protein; Homocysteine

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; HOMOCYSTEINE; MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; BLOOD VESSEL OCCLUSION; EDITORIAL; ENDOTHELIUM CELL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA;

EID: 42549127302     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.175588     Document Type: Editorial

References (29)

1. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149-1155.
2. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31-62.
3. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet. 1999;354:407-413.
4. Medina MA, Urdiales JL, Amores-Sánchez MI. Roles of homocysteine in cell metabolism. Eur J Biochem. 2001;268:3871-3882.
5. Perla-Kajan J, Twardowski T, Jakubowski H. Mechanisms of homocysteine toxicity in humans. Amino Acids. 2007;32:561-572.
6. Medina MA, Amores-Sánchez MI. Homocysteine: an emergent cardiovascular risk factor? Eur J Clin Invest. 2000;30:754-762.
7. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the nutrition committee, American Heart Association. Circulation. 1999;99:178-182.
8. Kullo IJ, Ballantyne CM. Conditional risk factors for atherosclerosis. Mayo Clin Proc. 2005;80:219-230.
9. Chang P-Y, Lu S-C, Lee C-M, Chen Y-J, Dugan TA, Huang WH, Chang S-F, Liao WSL, Chen C-H, Lee Y-T. Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation. Circ Res. 2008;102:933-941.
10. Jakubowski H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J. 1999;13:2277-2283.
11. Hultberg B, Andersson A, Isaksson A. Hypomethylation as a cause of homocysteine-induced cell damage in human cell lines. Toxicology. 2000;147:69-75.
12. Jakubowski H. Molecular basis of homocysteine toxicity in humans. Cell Mol Life Sci. 2004;61:470-487.
13. Gargalovic PS, Gharavi NM, Clark MJ, Pagnon J, Yang WP, He A, Truong A, Baruch-Oren T, Berliner JA, Kirchgessner TG, Lusis AJ. Arteriscler Thromb Vasc Biol. 2006;26:2490-2496.
14. Zhang C, Cai Y, Adachi MT, Oshiro S, Aso T, Kaufman RJ, Kitajama S. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem. 2001;276:35867-35874.
15. Roybal CN, Yang S, Sun CW, Hurtado D, Vander Jagt DL, Townes TM, Abcouwer SF. Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem. 2004;279:14844-14852.
16. Shastry S, Tyagi N, Hayden MR, Tyagi SC. Proteomic analysis of homocysteine inhibition of microvascular endothelial cell angiogenesis. Cell Mol Biol. 2004;50:931-937.
17. Duan J, Murohara T, Ikeda H, Sasaki K, Shintani S, Akita T, Shimada T, Imaizumi T. Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia. Arteroscler Thromb Vasc Biol. 2000;20:2579-2585.
18. Rodr?́guez-Nieto S, Chavarr?́a T, Mart?́nez-Poveda B, Sánchez-Jiménez F, Quesada AR, Medina MA. Anti-angiogenic effects of homocysteine on cultured endothelial cells. Biochem Biophys Res Commun. 2002;293:497-500.
19. Perna AF, Ingrosso D, De Santo NG. Homocysteine and oxidative stress. Amino Acids. 2003;25:409-417.
20. Zou CG, Banerjee R. Homocysteine and redox signaling. Antiox Redox Signal. 2005;7:547-559.
21. Wilcken DE, Wang XL, Adachi T, Hara H, Duarte N, Green K, Wilcken B. Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk. Arterioscler Thromb Vasc Biol. 2000;20:1199-1202.
22. Zappacosta B, Mordente A, Persichilli S, Minucci A, Carlino P, Martorana GE, Giardina B, De Sole P. Is homocysteine a pro-oxidant? Free Radic Res. 2001;35:499-505.
23. Drunat S, Moatti N, Paul JL, Cogny A, Benoit MO, Demuth K. Homocysteine-induced decrease in endothelin-1 production is initiated at the extracellular level and involves oxidative products. Eur J Biochem. 2001;268:5287-5294.
24. Rodr?́guez-Alonso J, Montañez R, Rodr?́guez-Caso L, Medina MA. Homocysteine is a potent modulator of plasma membrane electron transport systems. J Bioenerg Biomembr. 2008;40:45-51.
25. Liao D, Tan H, Hui R, Li Z, Jiang X, Gaubatz J, Yang F, Durante W, Chan L, Schafer AI, Pownall HJ, Yang X, Wang H. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I protein synthesis and enhancing HDL cholesterol clearance. Circ Res. 2006;99:598-606.
26. Chen CH, Jiang W, Via DP, Luo S, Li TR, Lee YT, Henry PD. Oxidized low-density lipoprotein inhibits endothelial cell growth by suppressing basic fibroblast growth factor expression. Circulation. 2000;101:171-177.
27. Chen CH, Jiang T, Yang JH, Jiang W, Lu J, Marathe GK, Pownall HJ, Ballantyne CM, McIntyre TM, Henry PD, Yang CY. Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation. 2003;107:2102-2108.
28. Lu J, Jiang W, Yang JH, Chang PY, Walterscheid JP, Chen HH, Marcelli M, Tang D, Liao WSL, Yang CY, Chen CH. Electronegative LDL impairs vascular endothelial cell integrity in diabetes by disrupting FGF2 autoregulation. Diabetes. 2008;57:158-166.
29. Chavarría T, Sánchez-Jiménez F, Quesada AR, Medina MA. Homocysteine inhibits the proliferation and invasive potential of HT-1080 human fibrosarcoma cells. Biochem Biophys Res Commun. 2003;301:540-544.